Antigen-Experienced CD4lo T Cells Are Linked to Deficient Contraction of the Immune Response in Autoimmune Diabetes by Linkes, Sean et al.
SAGE-Hindawi Access to Research
Autoimmune Diseases
Volume 2010, Article ID 920148, 14 pages
doi:10.4061/2010/920148
Research Article
Antigen-ExperiencedCD4lo TCellsAre Linkedto Deﬁcient
Contraction oftheImmuneResponseinAutoimmuneDiabetes
Sean Linkes, Christopher Fry, andAnthony Quinn
Department of Biological Sciences, University of Toledo, 2801 W. Bancroft, Toledo, OH 43606, USA
Correspondence should be addressed to Anthony Quinn, aquinn@utnet.utoledo.edu
Received 17 December 2009; Revised 24 April 2010; Accepted 19 August 2010
A c a d e m i cE d i t o r :I .R .M a c k a y
Copyright © 2010 Sean Linkes et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Following proper activation, na¨ ıve “CD4lo” T cells diﬀerentiate into eﬀector T cells with enhanced expression of CD4 -“CD4hi”
eﬀectors. Autoimmune diabetes-prone NOD mice display a unique set of antigen-experienced “CD4lo” T cells that persist after
primary stimulation. Here, we report that a population of such cells remained after secondary and tertiary TCR stimulation and
produced cytokines upon antigenic challenge. However, when NOD blasts were induced in the presence of rIL-15, the number
of antigen-experienced “CD4lo” T cells was signiﬁcantly reduced. Clonal contraction, mediated in part by CD95-dependent
activation-induced cell death (AICD), normally regulates the accumulation of “CD4hi” eﬀectors. Interestingly, CD95 expression
was dramatically reduced on the AICD-resistant NOD “CD4lo” T cells. Thus, while autoimmune disease has often been attributed
to the engagement of robust autoimmunity, we suggest that the inability to eﬀectively contract the immune response distinguishes
benign autoimmunity from progressive autoimmune diseases that are characterized by chronic T cell-mediated inﬂammation.
1.Introduction
Autoimmunity is a biological phenomenon wherein com-
ponents of the adaptive immune response target host-
derived molecules. Overt inﬂammatory autoimmune disease
is a condition mediated by autoimmune mechanisms that
directly or indirectly provoke tissue damage and bring about
physiological consequences with clinical sequelae [1]. Sur-
prisingly, autoimmunity may be quite common, primarily
existing in a benign form with no obvious clinical mani-
festations [2]. On the other hand, destructive inﬂammatory
autoimmunity is less prevalent and may be conﬁned to a
subset of individuals that share a common phenotype that
predisposesthemtospontaneousautoimmunedisease[3–5].
Heightened and chronic autoimmune responses characterize
organ-speciﬁc autoimmune diseases and may reﬂect poor
centraltoleranceor aninability to delete high aﬃnity autore-
active lymphocytes [6]. Alternatively, such clinical diseases
could be a reﬂection of a general defect in the regulation and
contraction of host immune responses that target self tissues
[7]. Extensive clonal expansion of antigen-activated lym-
phocytes is a fundamental feature of the adaptive immune
response in mammals; however, regulatory mechanisms are
necessarytopreventthelong-termaccumulationofactivated
eﬀectorTcells.Followingseveralroundsofclonalreplication
and expansion, the antigen-speciﬁc T cell repertoire con-
tracts to reestablish the homeostatic levels of lymphocytes
[8].Thisclonalcontractionismediatedinpartbyactivation-
induced cell death (AICD), a form of apoptosis that follows
repeated engagements of the T cells antigen receptor [9].
AICD can be induced in vitro when recently activated T cells
are restimulated through the TCR [9].
NOD mice spontaneously develop insulitis and type 1
diabetes (T1D), an autoimmune disease characterized by
T cell-mediated destruction of the insulin-producing beta
cells of the pancreas [1, 10]. The spontaneous appearance of
cellular immune responses to islet antigens and subsequent
immune-mediated pathology in the pancreas demonstrates
that NOD mice lack the ability to maintain immunological
homeostasis [11, 12], at least within particular organs [13].
A number of studies have provided evidence suggesting that
the mechanisms normally responsible for the induction and
maintenanceofself-tolerancemaybedefectiveinNODmice,
rendering them unable to provide adequate protection from
autoreactivity and autoimmune disease [10, 14]. NOD T
cells respond abnormally to religation of the TCR, which2 Autoimmune Diseases
is revealed in an initial hypoproliferative response [15, 16],
a pattern of altered primary T cell division [15–18]a n d
a failure to engage AICD upon subsequent challenge [19].
NOD mice are also deﬁcient in the production of cytokines
that can regulate T cell growth and diﬀerentiation [20, 21],
whichcouldleadtothecreationofskewedTcellpopulations.
Interestingly, a distinct subset of CD4loCD40+ T cells has
been described in NOD mice [22], which may be associated
with susceptibility to T1D. Contrastingly, full Th eﬀector
function may correlate with increased expression of the CD4
coreceptor, producing highly diabetogenic “CD4hi” T helper
cells [23, 24].
Previously, we demonstrated that autoimmune-prone
NOD mice display a defect in peripheral tolerance that is
independent of their unique class II MHC allele (I-Ag7)
[1], but involves regulatory mechanisms such as activation-
induced cell death (AICD) [19]. T cells in NOD mice may
be resistant to tolerogenic signals normally delivered during
thymic education [25] and those encountered in the periph-
ery [17, 19], resulting in a loss of regulation in the speciﬁc T
cell repertoires that contribute to chronic inﬂammation and
beta cell destruction in T1D. Here we report that a subset
of T cells in NOD mice is able to modulate CD4 expression
and escape AICD, despite multiple rounds of antigenic
stimulation. Defective cytokine-mediated maturation may
lead to the accumulation of previously activated autoreactive
Th cells in the periphery of NOD mice, predisposing them to
chronic inﬂammation.
2. Methods
2.1. Mice. Four-to 8-week-old female NOD mice were
purchasedfromTaconicFarms(GermantownNY).BALB/cJ,
NOD.Scid, and NOD.BDC2.5 TCR Tg mice were purchased
from The Jackson Laboratory (Bar Harbor, ME). The mice
were housed in pathogen-free conditions at the University of
Toledo (Toledo, OH).
2.2. T Cell Activation and Activation-Induced Cell Death
(AICD). Spleens were collected from na¨ ıve mice, dispersed
into single cell suspensions, and treated with red blood cell
lysingbuﬀer(SigmaAldrich,St.Louis,MO).Thesplenocytes
were washed and resuspended in complete medium (RPMI-
1640 supplemented with 10% fetal bovine serum, peni-
cillin/streptomycin, L-glutamine, nonessential amino acids,
sodium pyruvate, and β-mercaptoethanol) [26]w i t h0 . 5t o
2.5μg/mL of concanavalin A (Con A; Sigma) for 24–96
hours at 37◦C. For secondary stimulation and the induction
of AICD, Con A blasts were washed in complete medium
supplemented with 10ng/mL of recombinant human IL-2
(rIL-2), resuspended to 2.5 × 106 cells/mL in medium sup-
plemented with rIL-2, rested at 37◦Cf o r<3 hours, and then
plated in triplicate on antimouse CD3ε-coated 96-well plates
(50μl/wellfor2hrsat37◦C;clone145-2C11;BDBiosciences,
San Diego, CA). Hamster IgG-coated plates were used as
controls. For tertiary stimulation, Con A blasts recovered
fromanti-CD3-coated24-wellplateswererestedfor3daysin
rIL-2 and then challenged again on anti-CD3-coated plates.
To test proliferative responses, tritiated thymidine
(1.0μCi/well) (ICN Biomedicals Inc, Costa Mesa CA) was
addedtocellsin96-wellplatesforthelast16hoursofculture.
The plates were harvested and read in a Packard TopCount
NXT Microplate Scintillation and Luminescence Counter.
The results were expressed as mean cpm of triplicate wells.
Alternatively, the blasts were washed and placed in culture
with 10ng/mL of rIL-2 for three days to allow the “CD4lo”
T cells already in transition to become “CD4hi” T cells.
Afterwards, “CD4hi” and “CD4lo” T cells were separated via
Ficol Histopaque (Sigma) and analyzed by ﬂow cytometry
for the expression of CD4, CD62L, and CD69.
2.3. Cytokine-Induced Maturation of CD4lo T Cells. NOD
splenocytes were cultured for 72hrs in complete medium
with 100ng/mL of recombinant murine IL-2, IL-4, IL-7, or
IL-15 (Peprotech, Rock Hill, NJ) plus Con A, or Con A
alone. After primary stimulation the blasts were harvested
and analyzed by ﬂow cytometry for the expression of CD4.
Alternatively, 72-hour Con A blasts were washed and plated
intriplicateonanti-CD3-coatedorIgG-coated96-wellplates
for 48hrs. One hundred microliters of SN was collected from
eachwellandtestedforthepresenceofIFN-γ.Theremaining
cells were pulsed with tritiated-thymidine and harvested as
described above.
2.4. CFSE and Flow Cytometry. To monitor and enumerate
the cell divisions among T cells activated with Con A or
anti-CD3, spleen cells or blasts, respectively, were loaded
with CFSE (Molecular Probes, Eugene, Oregon). Brieﬂy, the
cells were resuspended to 1 × 107 cells/mL in RPMI, mixed
with an equal volume of CFSE (20nM), and incubated at
37◦Cf o r5m i n u t e s .A ne q u a lv o l u m eo fc o l dc o m p l e t e
medium was added to stop the reaction. Finally, the cells
were pelleted and resuspended in complete medium. For
primary stimulation, spleen cells were loaded with CFSE
prior to plating. Con A blasts were then incubated for 96
hours, pooled, and stained with ﬂuorochrome-labeled anti-
CD4 or anti-CD8, and analyzed by ﬂow cytometry. In some
experiments, ﬂow cytometry was performed at 24, 48, 72,
and 96 hours poststimulation. To monitor cell division after
secondary and tertiary stimulations, blasts were labeled with
CFSE and plated on anti-CD3-coated plates and harvested at
varioustimepoints(0,24,48,and72hours)poststimulation
(secondaryortertiary).Toevaluatetheactivationstatus,cells
were prepared as above and stained with antibodies to CD25,
CD62L, CD69, CD95, CD178, or TCR and counterstained
with anti-CD4. Typically, 20,000–100,000 events were col-
lected for ﬂow cytometric analysis of CD4lo T cells.
2.5. Cytokines and ELISA. IL-2, IL-4, IL-5, IL-10, and IFN-γ
were measured in culture supernatants at 24, 48, 72, and
96hrs after primary stimulation and 24, 48, and 72hrs after
secondary or tertiary stimulation as previously described
[27].
2.6. Adoptive Transfer Experiments. For adoptive transfer
of T1D and/or insulitis, spleen cells from NOD.BDC2.5
TCR transgenic mice were cultured for 72hrs in completeAutoimmune Diseases 3
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Figure 1:(a)SecondaryNODTcellblastsareresistanttoAICDupontertiaryrestimulation.NODorBALB/cConAblastswererestimulated
on anti-CD3-coated plates, washed, and cultured in IL-2-containing medium for 3 days then stimulated again on anti-CD3-coated plates
(0.003–3.0μg/mL;50μl/well).Tritium-labeledthymidinewasaddedforthelast16hrsofa72-hourculture.Thedataareexpressedaspercent
change versus control wells [(mean cpm anti-CD3 wells/mean cpm IgG wells) × 100]. The standard deviation of triplicate wells was less than
10%, and the results are representative of four experiments. (b) Culture supernatants were collected at various times (24–96hrs) following
primary stimulation (Con A) of NOD or BALB/c spleen cells or secondary and tertiary stimulations of T cells blasts with plate-bound anti-
CD3 (1.0μg/mL). IFN-γ levels were measured by ELISA, and the results are expressed as ng/mL. The results represent the mean and SD of
triplicate wells and are representative of 3 independent experiments. Only P-values that are <.05 are shown.
medium containing 2.5μg/mL of Con A. “CD4lo”-enriched
cells were recovered from the blasts by underlaying the Con
A blasts with Ficol Histopaque (Sigma) and centrifugation
to separate the smaller “CD4lo” from the “CD4hi” blasts.
AfterovernightcultureinIL-2containingmedium—toallow
complete transition of “CD4hi” cell—5 × 106, Con A blasts
or “CD4lo”-enriched cells were resuspended in 0.2mL of
PBS and injected into the peritoneal cavity of NOD.scid
mice, a least two per group. The recipient mice were tested
daily for glucosuria with Diastix (Fisher). All positives were
conﬁrmed by blood glucose measurements—levels above
250mg/dl were considered to be indicative of T1D. For the
evaluationofinsulitis,themicewereeuthanized10daysafter
adoptive transfer. For TID, groups of 4 mice were followed
for at least 30 days. Control mice received untreated spleen
cells from NOD.BDC2.5 TCR transgenic mice.
3. Results
3.1. NOD T Cells Proliferate in Response to Repeated Stimula-
tions through the TCR. To determine if defective engagement
of AICD was a stable phenotype in chronically activated
NOD T cells—retained through subsequent rounds of anti-
genic stimulation—viable NOD Con A blasts were cultured
for 72hrs on anti-CD3-coated plates (secondary), collected,
and restimulated again three days later in wells coated with
anti-CD3 (tertiary stimulation). Seventy-two hrs after the
third round of stimulation, we observed a >40% increase
in the proliferative response (Figure 1(a)) and a 10-fold
increase in the secretion of IFN-γ among NOD T cell blasts
(Figure 1(b)). Contrastingly, identical tertiary stimulation of
BALB/c T cell blasts resulted in a >60% reduction in the
proliferative response (Figure 1(a)) and a 90% reduction in
IFN-γ secretion (Figure 1(b))—similar suppression of T cell
activity has been attributed to AICD [9]. Thus, a detectable
n u m b e ro fN O DTc e l lb l a s t sa r ea b l et oe s c a p eA I C Dd u r i n g
primary,secondary,ortertiarystimulation,andaverystrong
crosslinking of the TCR is needed to force NOD T cell
blasts to undergo AICD, exempliﬁed by the 3μg/mL dose in
Figure 1(a).
3.2. NOD and BALB/c Blasts Express Similar Levels of
Activation Molecules. To demonstrate that the resistance to
AICD in NOD T cells was not due to poor engagement with
APC or to a lack of responsiveness to Con A, we compared
the surfaceexpression of activation molecules on splenocytes
from NOD and BALB/c mice, before and after activation.
There was no signiﬁcant diﬀerence between the two mouse
strains in the expression of CD25, CD44, CD69, CD95, or
CD178 on na¨ ıve CD4+ splenocytes (Figure 2). Following
three days of culture with Con A and recovery of viable cells,
viahistopaqueseparation,ﬂowcytometryshowedthatCD4+
splenic blasts from NOD and BALB/c mice had increased
expression of CD25, CD44, CD69, CD95, and CD178
(Figure 2). Importantly, CD95 (Fas) expression increased to
over 45% in both strains, while CD178 (FasL) expression4 Autoimmune Diseases
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Figure 2: The expression of CD25, CD44, CD69, CD95, and CD178 is similar on NOD and BALB/c CD4+ spleen cells. Naive spleen cells
or live Con A blasts (harvested by histopaque separation 72hrs after stimulation) from groups of 3 NOD or BALB/c mice were examined
individually by ﬂow cytometry for the expression of cell surface molecules associated with activation. The data are expressed as the mean
percentage of CD4+ cells (gated) that were positive for the respective molecule in groups of 3 mice, and the results are representative of 3
experiments, with at least 20,000 events collected in each experiment.
increased 3-4-fold, reaching maximal levels by 72 hours of
culture (Figure 2). Overall, both strains demonstrated an
ability to become engaged by Con A and upregulate surface
molecules associated with activation.
Since signaling through CD95 is needed to induce
AICD [28, 29], previously we evaluated the sensitivity of
histopaque-sorted NOD CD4+ T blasts to death induced by
ligationofCD95.WeshowedthatstimulationthroughCD95
resulted in lost proliferative responses in NOD and control
strains and a reduction in viable cell counts [19], suggesting
that the CD95 pathway, including the activation of caspase 8
and 3, was functional in the NOD T cell blasts.
3.3. NOD and BALB/c Mice Develop CD4hi T Cell Population
during Primary Stimulation. While an overall hypoprolif-
erative response characterizes the primary stimulation of
NOD T cells [15] ,c l e a r l yTc e l l sa r ea b l et oe x p a n da n d
cause pathology in the pancreas of such mice. One of the
striking features we noted in the primary response to Con A
was the consistent presence of a “CD4lo” T cell population
(MFI < 500) that remained among CFSE-loaded NOD
splenic T cells after stimulation with Con A (Figure 3(a)).
T h en u m b e ro f“ C D 4 l o ”Tc e l l sp r e s e n ti nN O DC o nA
blasts was signiﬁcantly higher than that in BALB/c blasts
(Figures3(a)and3(b)),despitethesimilararrayofactivation
markers (Figures 2 and 3(b)) expressed, while the number of
“CD4hi” T cells (MFI > 800) was reduced in the NOD blasts
(Figure 3(b)). The typical MFI is less than 500 for freshly
isolated na¨ ıve spleen cells stained with anti-CD4PE, “CD4lo”
and characterizes greater than 90% of the Th cells (data not
shown).Despitethedisparityin“CD4lo”Tcellcomposition,
approximately 35% of the Con A blasts were CD4+ in
both strains, suggesting that the transition to the “CD4hi”
phenotype may be altered in NOD mice. Additionally, fewer
cell divisions were associated with the “CD4lo” population
(Figure 3(a)).
To further examine proliferation and CD4 expression
among the blasts, CFSE-loaded spleen cells from NOD or
BALB/c mice were analyzed directly ex vivo (na¨ ıve), or 24–
72hrs after Con A stimulation. In both strains, the na¨ ıve Th
cells were all contained within a single “CD4lo” population
(Figure 4(a)). However, within 24hrs of stimulation the T
cell blasts began to increase in size (FSC), as expected,
and showed enhanced expression of the CD4 coreceptor
(Figure 4(a)). Within 72 hours of culture, the majority
of BALB/c CD4+ T cells had made the transition to the
“CD4hi” phenotype, but we consistently observed a number
of “CD4lo” T cells remaining among the NOD blasts
(Figure 4(a)), demonstrating that the “CD4lo” population
was detectable following activation. When we compared
T cell populations from NOD, with those of BALB/c, the
proliferative response for both was contained in the “CD4hi”
subset, which displayed losses in CFSE intensity (MFI, X-
axis) and concurrent increases in CD4 expression (MFI, Y-
axis) within 48hrs of stimulation (Figure 4(b)). Conversely,
the expression of CFSE in the “CD4lo” populations was
unchanged in both strains (Figures 4(b) and 4(c)). These
ﬁndings conﬁrmed that both “CD4hi” and “CD4lo” T cells
were present in blasts, each with a distinct proliferation
proﬁle, such that the hypoproliferative response appeared
to be associated primarily with the “CD4lo” population.
We also found the “CD4lo” T cells to be smaller than the
“CD4hi” when analyzed by ﬂow cytometry (forward scatter
(FSC), Figure 4(a)).
3.4. Hypoproliferating “CD4lo” T Cells Display Activation
Markers. Since hypoproliferation seem to be linked to the
“CD4lo” T cells, we analyzed the expression of activationAutoimmune Diseases 5
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Figure 3: “CD4lo” T cells are increased among NOD Con A blasts. (a) Spleen cells from na¨ ıve NOD or BALB/c mice were loaded with CFSE
and stimulated for 72hrs with Con A. The resulting blasts were stained with anti-CD4-PE and analyzed by ﬂow cytometry. The results are
representative of four experiments. The data are expressed as dot plots of ungated cells (100,000 events). The numbers in the plots represent
the percentage of total cells in regions R1 (CD4 MFI > 800) and R2 (CD4 MFI < 250). (b) The values in the bar graph reﬂect the mean
percentage of cells in each category, from 3 separate experiments (100,000 events collected for each sample). Student’s t-test was used to
compare responses between NOD and BALB/c blasts (only P-values reaching signiﬁcance, <.05, are shown).
markers on the “CD4lo” T cells to further conﬁrm that
they were not virgin cells. Con A activated “CD4lo” T cells
expressed levels of CD69 on their surface that were compara-
ble to the “CD4hi” (Figure 5(a)), but retained levels of CD4
that were similar to na¨ ıve NOD spleen cultured in complete
medium(Figure 5(d)).ConAactivationalsoresultedintwo-
thirds of the “CD4lo” T cells losing expression of CD62L
(Figure 5(b)), which is indicative of T cell activation. As
expected for a fully activated T cell population, some of the
“CD4hi” cells renewed the display of CD62L on their surface
(Figure 5(b)). Both “CD4hi” and “CD4lo” blasts expressed
CD25,althoughsomecellsfrombothgroupsdisplayedlower
levels of the cytokine receptor (Figure 5(c)). Additionally, we
found that the “CD4lo” T cells expressed CD40L at levels
that rivaled or surpassed that of the “CD4hi” cells (data not
shown)—the expression of CD40L has been linked to the
engagement of TCR and is thus another indicator of T cell
activation [30, 31].
Because it was possible that the hypoproliferating
“CD4lo” T cells represented a subset of NOD T cells express-
ing TCRs that responded poorly to Con A activation, we
analyzed clonotypic blasts that were produced from the
spleen cells of NOD.BDC2.5 TCR transgenic mice. We took
advantage of the size diﬀerence between the two subsets and
were able to enrich “CD4lo” T cells via Ficol Histopaque
centrifugation—the smaller, and more dense, “CD4lo” T
cells were contained in the pellet, while “CD4hi” cells were
found at the interface with the separation medium. Both
“CD4hi” and “CD4lo” cells were represented in the blasting
clonotypic T cells, with each group expressing CD69
(Figure 6(a)). Although all of the “CD4lo” T cells expressed
CD69, some of the “CD4hi” cells no longer expressed
the marker, perhaps an indication of their progres-
sion to memory cells. Importantly, to determine if
the “CD4loCD69+” clonotypic cells displayed true eﬀec-
tor functions that could inﬂuence physiology, enriched
“CD4loCD69+” BDC2.5 T cells, which lacked “CD4hi” T
cells, were injected into NOD.Scid mice. Both “CD4hi”
and “CD4lo” BDC2.5 clonotypic cells were able to transfer
insulitisintoNOD.scidmice(Figure 6(b));however,onlythe
recipients of “CD4hiCD69+” T cells developed severe insuli-
tis (88% of the islets showed invasive inﬂammation) and
overtdiabetes(100%,4/4)(Figure 6(b)anddatanotshown).
Only 45% percent of the islets were severely inﬂamed in
recipients of “CD4loCD69+” BDC2.5 blasts, while a nearly
equal number displayed peri-insulitis (Figure 6(b) and data
not shown). None of the mice from the “CD4lo” group (0/4)
progressed to hyperglycemia. Thus, while they possess the
ability to invade the target tissue, the “CD4lo” T cells were
not as diabetogenic as the “CD4hi” T cells. The naive clono-
typic spleen cells lacked the invasive ability (Figure 6(b)).
When spleen cells from NOD.scid recipients of “CD4lo”
BDC2.5 clonotypic T cells were analyzed, only “CD4lo”
T cells were detectable in the TCR V beta 4+ population
(Figure 6(c)), indicating that the “CD4lo” had not diﬀeren-
tiated into “CD4hi” T cells prior to achieving the ability to
inﬁltratethepancreasandinduceinsulitis.Itshouldbenoted
that the “CD4hi” population contained both phenotypes of
T cells before and after transfer.
To determine if the “CD4lo” phenotype among Con
A blasts was preserved upon further TCR stimulation,
“CD4hi” T cells were removed from NOD Con A blasts
via Ficol Histopaque separation. After conﬁrming that the
remaining “CD4lo” enriched-blasts contained less than 5%6 Autoimmune Diseases
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Figure 4: CD4 expression and T cell size increase in T cells undergoing cell division. CFSE-loaded NOD or BALB/c spleen cells were
stimulated with Con A, harvested at 24 or 72hrs, and then counterstained with anti-CD4-PE and CD3-PE/Cy5. For FACS analysis, 100,000
events were collected. The plot represents gated CD3+ cells. (a) Temporal analysis of CD4 expression and size (FSC) among Con A blasts.
(b) CD4 expression and cell division (CFSE) in Con A blasts. The mean ﬂuorescence intensity (MFI) for CFSE (X)a n dC D 4( Y) expression
is noted for CD4+ cells at 24 and 48hrs. (c) The pattern of CFSE expression (cell division) amongst CD4hi and CD4lo T cells from NOD or
BALB/c Con A blasts 72hrs after stimulation.
“CD4hi”, the cells were labeled with CFSE and cultured
on plates coated with anti-CD3 antibody. Within 24hrs it
was apparent that the “CD4lo” population had undergone
at least one cell division, with many remaining “CD4lo” T
cells; however, the stimulation also gave rise to a paucity
of “CD4hi” T cells with reduced CFSE (Figure 7). After
48hrs, another cell division occurred, producing a more
pronounced population of “CD4hi” cells (Figure 7), thus
demonstrating that “CD4loCD69+” T cells could give rise
to “CD4hi” T cells. Nevertheless, a population of hypopro-
liferative “CD4lo” T cells still remained after the secondary
challenge (Figure 7).
3.5. Cytokines Induce Diﬀerentiation of CD4lo T Cells. Since
we were unable to correct the hypoproliferative response
in the NOD “CD4lo” T cells by increasing signal strengthAutoimmune Diseases 7
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Figure 5:The“CD4lo”TcellsthatpersistamongNODConAblastsareantigen-experienced.NODspleencellswereculturedfor72hrswith
Con A, stained with anti-CD4-PE and anti-CD69-FITC (a), anti-CD62L-FITC (b), or anti-CD25-FITC (c), and analyzed by ﬂow cytometry
(20,000events were collected foreach analysis). Theselected regions (boxes) inthedotplots markthe“CD4lo” population,and thenumbers
indicate their percentage in the total population. The underlined numbers indicated the percentage of CD4+ cells in the total population.
(d) Freshly isolated NOD splenocytes were stained with anti-CD4-PE and IgG-FITC for comparison to baseline CD4 expression on na¨ ıve T
cells. These data are representative of two experiments.
through the TCR (increasing Con A or anti-CD3 concen-
trations), we investigated the role of soluble growth factors,
such as cytokines, in altering the persistence of “CD4lo” T
cells. Several of our preliminary experiments suggested that
supernatants recovered from BALB/c Con A blasts could
ameliorate the hypoproliferative response in NOD blasts
when added during the primary stimulation. Therefore, to
determine if speciﬁc cytokines could alter the persistence of
“CD4lo” T cells, splenocytes from NOD or NOR/Lt mice
were activated with Con A in the presence of recombinant
mouse IL-2, IL-4, IL-7, or IL-15 and then challenged 72hrs
later on anti-CD3-coated plates. As was expected [19], the
antigenic challenge of the blasts caused a reduction in
the proliferative response of NOR/Lt T cell blasts (−26%)
(Table 1), while inciting proliferation among the NOD blasts
(+50%) (Table 1). The NOD blasts established in the pres-
ence of IL-4, IL-7, and IL-15 showed signiﬁcantly enhanced
proliferation; IL-15 produced the most dramatic increase
(Table 2). The impact of the cytokines was less striking
on NOR/Lt blasts, as none increased proliferation by more
than 50%, although the response with supplemented IL-15
was signiﬁcantly higher than the media control (Table 1).8 Autoimmune Diseases
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dot plots indicate the percentage of total cells that are within a region. A total of 20,000 events were collected for each plot. (b) 5 × 106
“CD4lo”-enriched or “CD4hi”-enriched T cells were each adoptively transferred into 6 NOD.scid mice. As a control, untreated BDC2.5 TCR
Tg spleen cells were also transferred into a control group of NOD.scid mice. Ten days later the pancreas was recovered from at least two
mice per group, ﬁxed, embedded, and cut into 5 micron sections that were subsequently stained with hematoxylin and eosin. The sections
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Figure 7: Antigen-experienced “CD4lo” T cells give rise to “CD4hi” T cells. “CD4lo” T cells were enriched from the Con A blasts of NOD
s p l e e nc e l l sa sd e s c ri b e di nFigure 6. The “CD4lo” T cells or Con A blasts were cultured overnight in IL-2-containing complete medium, then
each was labeled with CFSE before incubation on anti-CD3-coated plates. Twenty-four and 48hrs later the cells were labeled with anti-CD4-
PE and analyzed by ﬂow cytometry to reveal cell divisions. Proliferating “CD4hi” T cells arising from the blasts are indicated in the encircled
population the numbers indicate the percentage in the total cell population. For each analysis, 100,000 events were collected, and the results
are representative of four experiments.
IL-2 was unable to enhance proliferation and may have
actually enhanced cell death in blasts from both mouse
strains (Table 1). The exposure to the cytokines did not
appear to interrupt the blast’s ability to respond to secondary
antigenic challenge, as anti-CD3 was able to induce IFN-γ
under all conditions tested (Table 1).
To determine if enhanced proliferation would lead to
alterations in the unique expression of CD4lo/CD4hi phe-
notype in NOD T cell blasts, we analyzed CD4 expression on
Con A blasts incited in the presence of exogenous cytokine,
24 and 72hrs after challenge with plate-bound anti-CD3.
In the presence of IL-15, the percentage of “CD4hi” nearly
tripled in the ﬁrst 24hrs and almost reached a fourfold
increase by 72hrs (Table 2). Similar increases were observed
at 24 and 72hrs with IL-4, while the eﬀects of IL-2 and IL-
7 were less pronounced and best seen at 72hrs (Table 2).
A decrease in the percentage of “CD4lo” was concomitant
with the increase in “CD4hi” T cells (Table 2). Therefore,
four cytokines that bind to receptors that share the common
g a m m ac h a i nw e r ea b l et od r i v et h ed i ﬀerentiation of NOD
“CD4lo” T cells into typical “CD4hi” T cells.
3.6. Poor Expression of CD95 on CD4lo T Cells. Since CD95
has been linked to AICD, we evaluated the expression
of the death receptor on the two CD4 subsets. A popu-
lation CD4hiCD95hi cells was highly increased following
Con A activation of both BALB/c and NOD spleen cells
(Figure 8(a)). However, in contrast to CD25 and CD69,
the “CD95hi” T cells existed almost solely in the “CD4hi”
subset, demonstrating that the transition to “CD4hi” results
in an increase in CD95 expression (Figure 8(a)). The MFI for
CD95stainingonthe“CD4lo”cellswas<127forbothgroups10 Autoimmune Diseases
NOD BALB/c
NOD BALB/c
100
100
101
101
102
102
103
103
104
104 100 101 102 103 104
100 101 102 103 104 100 101 102 103 104 100
101
102
103
104
100
101
102
103
104
100
101
102
103
104
C
D
9
5
C
D
9
5
C
D
9
5
C
D
9
5
CD4 CD4
CD4 CD4
0.5%
30.6% 30.4%
28.1%
4%
0.7%
8.1%
24.5%
C
o
n
A
b
l
a
s
t
s
C
o
n
A
b
l
a
s
t
s
R1
R1
R1
R1
R2
R2
R2
R2
N
a
¨
ı
v
e
N
a
¨
ı
v
e
(a)
0
10
20
30
40
50
60
CD4+ (total) CD4loCD95hi CD4hiCD95hi
Con A blast-72hr
NOD
BALB/c
P<.037
V
i
a
b
l
e
c
e
l
l
s
(
%
)
(b)
Figure 8: CD95 is poorly expressed on antigen-experienced CD4lo T cells. (a) Na¨ ıve and Con A activated spleen cells pooled from two
NOD or BALB/c mice were stained with anti-CD4 and CD95. R1 denotes region of double positive cells, CD4hiCD95hi, in Con A blasts. R2
denotes the region of single positive cells, CD4loCD95(−). Twenty-thousand events were collected for the analysis. The numbers indicate
the percentage of the total population that resides in R1 or R2. (b) A summary of 3 experiments performed as in (a), representing the mean
and SD from 3 individual mice. The P-values are only displayed for those comparisons between NOD and BALB/c that were below .05.
of na¨ ıve T cells. Upon activation, the expression increased
to yield distinct populations with MFIs of 394 and 311 on
the “CD4hi” cells of BALB/c and NOD, respectively. On the
other hand, a residual group of “CD4lo” T cells with a poor
expression of CD95 (MFI = 75) remained among the NOD
blasts. Similar results were observed in multiple experiments
(Figure 8(b)).
4. Discussion
The ability to control overly aggressive immune responses
may provide an important distinction between benign
autoimmunity and chronic inﬂammatory autoimmune dis-
ease. Chronicity and dysregulation are critical aspects of
autoimmunityindestructiveautoimmunediseases,suchthat
individuals who spontaneously develop autoimmune disease
m a yb el e s se ﬀective in reinstating immunologic homeostasis
and peripheral tolerance once autoimmunity has been
initiated. Here, we investigated the relationship between T
cell activation and cytokine driven T cell maturation in
the NOD mouse model of autoimmunity. We found that
the T cell hypoproliferative response and persistence of
immunity in NOD mice were associated with “CD4lo” T
cells, which appear to represent a subset that is encumbered
in its progression to complete maturation and “full eﬀector”
status. The previously activated “CD4loCD69+” T cells
may serve as a reservoir in the chronic autoimmunity and
inﬂammation observed in NOD mice since such cells might
be unreceptive to peripheral regulation via AICD due to
poor or defective expression of the CD95 death receptor. The
failure of “CD4lo” T cell blasts to progress to the “CD4hi”
phenotype was corrected by the addition of cytokines that
share the common gamma chain receptor, IL-4, IL-7, and
IL-15 [20, 21]. Interestingly, IL-4 is associated with the
prevention or delay of T1D [32–35], but the protection has
typically been linked to the cytokines ability to antagonize
Th-1 responses [34, 35] and regulate the proinﬂammatory
milieufoundinprediabeticNODislets[36,37].Ourﬁndings
suggest that the ability of IL-4 to drive T cell maturation may
also contribute to its favorable impact on T1D.
IL-4, IL-7, and IL-15 are important T cell growth and
diﬀerentiation factors [20, 21]. The addition of IL-15 and
IL-4 to in vitro cultures can increase the survivability of
activated T cells, as can IL-7 and IL-2, with the latter
two cytokines having less eﬃciency [38]. Here we show
that the addition of IL-4, IL-7, or IL-15 at the time of
activation enhances the transition of NOD “CD4loCD69+”
into “CD4hi” eﬀectors and rectiﬁes the hypoproliferative
response in the spleen. IL-4 has previously been shown
to reverse the hypoproliferation in NOD thymocytes [15,
17]. It remains to be determined whether IL-15 and IL-
7 can also correct the hypoproliferative response in NOD
thymocytes or prevent T1D. Similar to its limited eﬀect on
T1D [32], IL-2 only partially corrected the delayed transition
of “CD4loCD69+” T cells in our experiments. Additional
studies are necessary to determine if IL-7 and IL-15 are
qualitatively unique in NOD mice or if the expression
levels are quantitatively diﬀerent from that of healthy mice.
Certainly there are precedents for both, as allelic variants
of IL-2/IL2R may be major contributors to T1D in NOD
mice [32, 39, 40]. Importantly, inadequate signaling through
the common cytokine receptor γ chain is associated with an
accumulation of T cells in the spleen [21].
Similar to the reports of others [23], we found that
the expression of CD4 on Th cells from NOD and healthy
controls increases following activation; however, NOD
Con A blasts were unique, with a signiﬁcant population
of “CD4lo” remaining after multiple rounds of in vitroAutoimmune Diseases 11
Table 1: The addition of cytokines to the primary stimulation
increases the proliferative response in NOD Con A blasts upon
secondary challenge with anti-CD3.
Conditions of primary
blasts stimulationa
Secondary
proliferationb
Stimulation
indexc
IFNγ
absorbanced
NOD
Con A (no 20)2 2 0 . 2 4
Con A 33∗ 1.50∗∗ 1.13
Con A+IL-2 30 1.36∗∗ 1.01
Con A+IL-4 42∗ 1.91 1.21
Con A+IL-7 60∗ 2.72∗∗ 1.31
Con A+IL-15 90∗ 4.09∗∗ 1.51
NOR
Con A (no 20)3 8 0 . 3 0
Con A 28∗ 0.74 1.54
Con A+IL-2 23∗ 0.61 1.35
Con A+IL-4 42 1.11 1.42
Con A+IL-7 42 1.11 1.38
Con A+IL-15 52∗ 1.37 1.65
aSplenocytes were cultured for 72hrs with 2.0μg/mL of Con A, with or
without recombinant mouse IL-2, IL-4, IL-7, or IL-15.
bCon A blasts were plated in triplicate on IgG-coated (no 20) or anti-CD3-
coated plates for 48hrs, pulsed with H3-thymidine for an additional 18hrs,
harvested, and read in a beta counter. The results are the means, rounded to
the nearest 104 CPM. The SD was less than 10%. The asterisk (∗) indicates
P<. 05, when compared to proliferation on IgG coated plate.
cThe stimulation index (SI) was calculated as mean experimental (anti-CD3
plate) CPM/ mean Con A control (IgG plate) CPM. The two asterisks (∗∗)
indicate that P<. 05 when the NOD SI was compared to the SI of NOR
blasts treated under the same conditions.
dSupernatants collected 48hrs after culture on IgG or anti-CD3-coated
plates were tested by ELISA. The results are expressed as mean absorbance
(405nm) of duplicate wells. The absorbance values (1.0–1.54) represent an
IFN-γ concentration range of 1.5–2.5ng/mL.
Table 2: The addition of cytokines during primary stimulation
increases the transition of na¨ ıve NOD T cells to CD4hi eﬀectors.
Primary stimulationa 24hrb 72hrb
CD4loc CD4hi CD4lo CD4hi
Con A 58% 10 50 12
Con A+IL-2 42∗ 14 25∗ 21∗
Con A+IL-4 42∗ 25∗ 14∗ 39∗
Con A+IL-7 42∗ 15 22∗ 28∗
Con A+IL-15 40∗ 30∗ 19∗ 40∗
a Splenocytes were cultured in 24-well plates for 72hrs with 2.0μg/mL of
Con A, with or without recombinant mouse IL-2, IL-4, IL-7, or IL-15.
b Twenty-four or 72hrs after the addition of Con A, the cells were collected
and stained with anti-CD4-PE and analyzed by ﬂow cytometry. The data
are expressed as mean percentage of “CD4lo” and “CD4hi” cells in triplicate
wells, amongst the total CD4+ population. The SD was less than 20%. The
asterisk (∗) indicates that P<. 05 when compared to Con A blasts induced
without cytokines added. The results are representative of two experiments.
stimulation. This population of antigen-experienced
“CD4lo” was present regardless of the concentration of
Con A or anti-CD3 used to initiate the primary T cell
activation. The “CD4lo” T cells were not na¨ ıve, unprimed
T cells that failed to respond to TCR stimulation, as
they showed increased expression of CD69 and a loss
of CD62L. Furthermore, in contrasts to na¨ ıve “CD4lo”
BDC2.5 T cells, clonotypic “CD4loCD69+” blasts from
BDC2.5 TCR transgenic mice were able to induce insulitis in
NOD.scid mice, suggesting that the adhesion molecules and
chemotactic receptors necessary for extravasation were also
expressed by the latter T cell population. BALB/c-derived
na¨ ıve “CD4lo” T cells were much more eﬃcient in making
the transition to the “CD4hi” phenotype, with the process
being95–97%eﬀective.ManyoftheCD4+ TcellsfromNOD
mice made the transition to “CD4hi,” but at a much lower
rate—70–75%. Paradoxically, the delayed transition into
full eﬀector status could contribute to the interval between
insulitis and the onset of T1D, as some “CD4loCD69+” T
cells may escape regulation, transition to “CD4hi” upon
encountering antigen and later contribute to the destructive
phase of insulitis—adoptive transfer experiments have
shown that as few as 500 islet-derived “CD4hi” T cells
can transfer T1D and only 200 are needed for tissue-
speciﬁc inﬁltration and inﬂammation [24]. The activated
“CD4loCD69” BDC2.5 transgenic T cells described here
may have diabetogenic potential [24], but the incubation
time needed after adoptive transfer may be beyond the
period we tested. The extended time needed for disease
transfer could be due to a need for the “CD4lo” T cells
to upregulate CD4 and become fully functional eﬀectors.
The precise role of “CD4lo” T cells in T1D is unclear, as
some have observed “CD4loCD40+” T cells to be highly
diabetogenic [22], while others report that the “CD4hi”
phenotypes are a characteristic of the most diabetogenic T
cells [24]. Our ﬁndings were more consistent with the latter,
as “CD4hi” T cells from BDC2.5 TCR Tg mice were more
eﬃcient at inducing T1D upon adoptive transfer. It should
be noted that the “CD4hi” T cells were best observed when
the anti-CD4 antibody was conjugated to PE.
While extensive clonal expansion of activated lympho-
cytes is a fundamental feature of the adaptive immune
response, mechanisms exist to prevent the chronic accu-
mulation of such activated T cells. Activation-induced cell
death (AICD) contributes signiﬁcantly to the contraction of
the activated lymphocyte pool [28, 29]. Following antigen-
exposure, T cells diﬀerentiate into distinct populations that
vary in susceptibility to AICD upon engagement of their
antigen receptors: na¨ ıve and long-lived memory T cells are
much more resistant to AICD than eﬀector T cells [41–44].
We found that NOD “CD4hi” T cells expressed CD95 and
were very susceptible to AICD induced by the crosslinking
of CD95, conﬁrming that the CD95 pathway, including the
downstream eﬀector molecules were functional in NOD
“CD4hi” T cells (data not shown). Contrastingly, the NOD
“CD4loCD69+” T cells appear to represent a population that
is able to modulate its sensitivity to AICD by altering the
expression of receptors/ligands like CD95.
It is evident that naive CD4+ T cells encounter antigen
in a state where the total surface expression of CD4 is
reduced, compared to recently activated blasts; however, the
connection between TCR signaling and CD4 expression is12 Autoimmune Diseases
not completely clear. The TCR signaling cascade is essential
for activation, diﬀerentiation, and AICD, and several kinases
are inﬂuential in TCR signaling, including Lck and ZAP-70
[45, 46]. The recruitment of Lck correlates with increased
AICDinmaturecyclingTcells[47,48],providingsupportive
evidence for Lck activity leading directly or indirectly to the
upregulation of CD95 on the cell surface. The expression or
functional activity of Lck may be defective in NOD mice—
Lck is recruited to the TCR less frequently in activated NOD
thymocytes when compared to a healthy control strain [18].
As a result of decreased Lck frequency, a disproportionate
numberofNODCD4+ Tcellsma ynotexperiencefullactiva-
tionandsubsequenteﬀectorfunctionasdemonstratedbythe
residual “CD4lo” population. In addition, Lck recruitment
to the T signaling scaﬀold also impacts activation of ZAP-
70, costimulation, and the MAPK kinase pathways [49, 50],
which can eﬀect cytokine production. The decreased Lck
kinaseactivityinNODmicemayalsohaveanindirectimpact
on AICD by compromising T cell secretion of cytokines
needed for reaching a critical threshold of divisions, and
susceptibility to AICD [8].
5. Conclusion
Poor thymic selection via unique MHC molecules likely
contributes signiﬁcantly to the selection of autoreactive T
cells. However, a compromised ability of such T cells to fully
diﬀerentiate and engage the proper regulatory mechanisms
in at-risk individuals may also contribute signiﬁcantly to
the chronic inﬂammation and postadolescent onset that
characterizes many autoimmune diseases. Poor peripheral
regulation could result in the formation of a repository of
autoreactive T cells that have a threshold for activation lower
than that of na¨ ıve cells-γ c-deﬁcient mice show an age-
dependent accumulation of activated T cells in the spleen
and CD4−/− T cells have been shown to survive repeated
antigenic challenge and activation-induced apoptosis [51].
Chronic inﬂammation could arise in mice where T cells
poorly express CD4, but have speciﬁcity for target antigens
that persist in vivo. This chronic response may not be
observed with foreign antigens since the stimulating epitope
would be lost once the antigen depot is cleared—barring
molecular mimicry. Thus, new considerations must be exer-
cisedwhendevelopingtherapeuticssincecorrectingimmune
dysregulation in autoimmune-prone individuals may be
more challenging than that observed in normal healthy
individuals, such that paradigms for tolerance induction
developed in healthy mice may not be directly applicable to
autoimmune-prone individuals.
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